Signatures of mutational processes in human cancerTon N. Schumacher, Christine Desmedt, Roland Eils et al.|Nature|2013Cited by 10.1k
Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Jamie E. Chaft et al.|New England Journal of Medicine|2018Cited by 2.1k
Physiology of diving of birds and mammalsP. J. Butler, David R. Jones|Physiological Reviews|1997Cited by 608
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)Tricia R. Cottrell, Janis M. Taube, Elizabeth D. Thompson et al.|Annals of Oncology|2018Cited by 588
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X. Caushi, Kellie N. Smith, Taha Merghoub et al.|Nature|2021Cited by 546